Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.

Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.


English

0167-5273


*Acute Coronary Syndrome/dt [Drug Therapy]
*Adenosine/aa [Analogs & Derivatives]
*Blood Platelets/de [Drug Effects]
*Drug Substitution/mt [Methods]
*Piperazines/ad [Administration & Dosage]
*Purinergic P2Y Receptor Antagonists/ad [Administration & Dosage]
*Thiophenes/ad [Administration & Dosage]
*Ticlopidine/aa [Analogs & Derivatives]
Acute Coronary Syndrome/bl [Blood]
Adenosine/ad [Administration & Dosage]
Aged
Blood Platelets/me [Metabolism]
Female
Humans
Male
Middle Aged
Prospective Studies
Ticlopidine/ad [Administration & Dosage]
Treatment Outcome


MedStar Heart & Vascular Institute.


Comparative Study
Letter

Powered by Koha